Alessandro De Bortoli, Ingvild Nordøy, James Patrick Connelly, Hans-Kittil Viermyr, Randi Haukaas Bjerkreim, Kaspar Broch, Paul Anders Sletten Olsen, Einar Gude, Børre Fevang, Silje F Jørgensen, Marius Trøseid, Torkel Steen, Pål Aukrust, Arne K Andreassen, Tonje Skarpengland
BACKGROUND: Evidence-based guidelines for cardiac sarcoidosis (CS) regarding use of second- and third-line agents, treatment duration, surveillance and prognostic factors are lacking. OBJECTIVE: To analyze the clinical presentation, diagnostics, treatment, monitoring and clinical outcomes in a Norwegian cohort. METHODS: Using discharge diagnoses between 2017 through 2020 from a large tertiary center, we identified 52 patients with CS. We performed a systematic chart review following a pre-specified checklist...
January 23, 2024: International Journal of Cardiology